Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1971-12-30
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Biology, http://linkedlifedata.com/resource/pubmed/keyword/Clinical Research, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents, Female--side..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents--side effects, http://linkedlifedata.com/resource/pubmed/keyword/Diseases, http://linkedlifedata.com/resource/pubmed/keyword/Endometrial Effects, http://linkedlifedata.com/resource/pubmed/keyword/Endometrium, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, Female, http://linkedlifedata.com/resource/pubmed/keyword/Histology, http://linkedlifedata.com/resource/pubmed/keyword/Injectables, http://linkedlifedata.com/resource/pubmed/keyword/Norethindrone Enanthate--side effects, http://linkedlifedata.com/resource/pubmed/keyword/Norethindrone--side effects, http://linkedlifedata.com/resource/pubmed/keyword/Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology, http://linkedlifedata.com/resource/pubmed/keyword/Urogenital System, http://linkedlifedata.com/resource/pubmed/keyword/Uterus, http://linkedlifedata.com/resource/pubmed/keyword/VAGINITIS, http://linkedlifedata.com/resource/pubmed/keyword/Vaginal Abnormalities, http://linkedlifedata.com/resource/pubmed/keyword/Vaginal Desquamate Effects
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0025-8512
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1551-3
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: Clinical experiences and biological parameters with injections of no rethisterone enanthate (200 mg) given at intervals of 84 days in 10 women aged 20-38 years are reported. Total gonadotropin excretion was decreased in 9 patients and urinary pregnanediol decreased by 50% in all patients. Basal temperature levels remained about .5 degrees C higher for 4-6 weeks after injections. Endometrial biopsies revealed proliferation and secretion phases and slight evidence of an anti-estrogenic effect, but atrophic or hyperplastic changes were not seen. The antiestrogenic effect was also observed in the vaginal epithelium. Other biological parameters were considered normal (plasma cortisol rise after ACTH, oral glucose tolerance, protein-bound iodine, serum cholesterol and total lipids, and liver tests). Side effects included cycle irregularities, spotting, breakthrough bleeding, and weight changes of less than 3 kg. No pregnancies occurred.
pubmed:meshHeading
pubmed:year
1971
pubmed:articleTitle
[3 months contraception with norethisteronönantate. Clinical and biochemical studies].
pubmed:publicationType
Journal Article, English Abstract